Revenue: The sum of all revenue fields included for a company's operating activities.
Infinity Pharmaceuticals, Inc. (INFIQ) had Revenue of $0.58M for the most recently reported fiscal quarter, ending 2023-06-30.
| Income Statement Financials | |
|
Revenue |
$0.58M |
$-9.96M |
|
-- |
|
$0.58M |
|
$10.70M |
|
$-10.12M |
|
$0.16M |
|
$-9.96M |
|
$-9.96M |
|
$-9.96M |
|
$-9.96M |
|
$-9.96M |
|
$-9.96M |
|
$-10.12M |
|
$-10.01M |
|
89.89M |
|
89.89M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$19.91M |
|
$0.59M |
|
$1.32M |
|
$21.23M |
|
$12.06M |
|
-- |
|
$46.57M |
|
$58.64M |
|
$-37.41M |
|
$-37.41M |
|
$-37.41M |
|
90.76M |
|
| Cash Flow Statement Financials | |
$-20.58M |
|
-- |
|
$0.02M |
|
$38.47M |
|
$17.90M |
|
$-20.57M |
|
$2.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1735.85% |
|
-1735.85% |
|
-- |
|
-1707.72% |
|
-1707.72% |
|
$-20.58M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
26.62% |
|
26.62% |
|
-46.89% |
|
26.62% |
|
$-0.41 |
|
$-0.23 |
|
$-0.23 |
|